Department of Surgery, Division of Surgical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Ann Surg Oncol. 2010 Mar;17(3):812-20. doi: 10.1245/s10434-009-0827-4.
In esophageal cancer, circumferential resection margins (CRMs) are considered to be of relevant prognostic value, but a reliable definition of tumor-free CRM is still unclear. The aim of this study was to appraise the clinical prognostic value of microscopic CRM involvement and to determine the optimal limit of CRM.
To define the optimal tumor-free CRM we included 98 consecutive patients who underwent extended esophagectomy with microscopic tumor-free resection margins (R0) between 1997 and 2006. CRMs were measured in tenths of millimeters with inked lateral margins. Outcome of patients with CRM involvement was compared with a statistically comparable control group of 21 patients with microscopic positive resection margins (R1).
A cutoff point of CRM at < or = 1.0 mm and > 1.0 mm appeared to be an adequate marker for survival and prognosis (both P < 0.001). The outcome in patients with CRMs < or = 1.0 and > 0 mm was equal to that in patients with CRM of 0 mm (P = 0.43). CRM involvement was an independent prognostic factor for both recurrent disease (P = 0.001) and survival (P < 0.001). Survival of patients with positive CRMs (< or = 1 mm) did not significantly differ from patients with an R1 resection (P = 0.12).
Involvement of the circumferential resection margins is an independent prognostic factor for recurrent disease and survival in esophageal cancer. The optimal limit for a positive CRM is < or = 1 mm and for a free CRM is >1.0 mm. Patients with unfavorable CRM should be approached as patients with R1 resection with corresponding outcome.
在食管癌中,环周切缘(CRM)被认为具有重要的预后价值,但肿瘤无 CRM 的可靠定义仍不清楚。本研究旨在评估微观 CRM 受累的临床预后价值,并确定 CRM 的最佳界限。
为了定义最佳的无肿瘤 CRM,我们纳入了 98 例在 1997 年至 2006 年间接受扩大食管切除术且具有微观无肿瘤切缘(R0)的连续患者。用墨水标记的侧缘以十分之一毫米测量 CRM。将 CRM 受累患者的结局与 21 例具有微观阳性切缘(R1)的统计学可比对照组进行比较。
CRM 小于或等于 1.0mm 和大于 1.0mm 的截止点似乎是生存和预后的有效标志物(均 P<0.001)。CRM 小于或等于 1.0mm 和大于 0mm 的患者的结局与 CRM 为 0mm 的患者的结局相当(P=0.43)。CRM 受累是复发性疾病(P=0.001)和生存(P<0.001)的独立预后因素。阳性 CRM(小于或等于 1mm)患者的生存与 R1 切除患者无显著差异(P=0.12)。
环周切缘受累是食管癌复发和生存的独立预后因素。阳性 CRM 的最佳界限为小于或等于 1mm,无肿瘤 CRM 的最佳界限为大于 1.0mm。具有不利 CRM 的患者应作为 R1 切除患者处理,具有相应的结局。